533 related articles for article (PubMed ID: 8457639)
21. [Index of fibrinolysis with new fibrin plate (author's transl)].
Hishikawa Y; Sugie I
Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
[TBL] [Abstract][Full Text] [Related]
22. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
[TBL] [Abstract][Full Text] [Related]
23. [A method for determining plasmin by the rate of fibrin gel lysis].
Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF
Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408
[TBL] [Abstract][Full Text] [Related]
24. Insight into the profibrinolytic activity of dermatan sulfate: effects on the activation of plasminogen mediated by tissue and urinary plasminogen activators.
Castañon MM; Gamba C; Kordich LC
Thromb Res; 2007; 120(5):745-52. PubMed ID: 17270255
[TBL] [Abstract][Full Text] [Related]
25. Activation of the fibrinolytic system.
Robison AK; Collen D
Cardiol Clin; 1987 Feb; 5(1):13-9. PubMed ID: 3103919
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of human plasminogen activator and of a fraction of fibrinolytically active plasma enriched with this enzyme].
Plastonova TK; Petrenko OA
Vopr Med Khim; 1979; 25(3):302-7. PubMed ID: 156462
[TBL] [Abstract][Full Text] [Related]
27. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy].
Veremeenko KN; Kizim AI
Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892
[TBL] [Abstract][Full Text] [Related]
28. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
Dupe RJ; English PD; Smith RA; Green J
Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
[TBL] [Abstract][Full Text] [Related]
29. Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.
Sakharov DV; Barrertt-Bergshoeff M; Hekkenberg RT; Rijken DC
Thromb Haemost; 1999 Apr; 81(4):605-12. PubMed ID: 10235448
[TBL] [Abstract][Full Text] [Related]
30. Coronary thrombolysis: pharmacological considerations with emphasis on tissue-type plasminogen activator (t-PA).
Fox KA; Bergmann SR; Sobel BE
Biochem Pharmacol; 1984 Jun; 33(12):1831-8. PubMed ID: 6233982
[No Abstract] [Full Text] [Related]
31. Interaction of plasminogen activators and plasminogen with heparin: effect of ionic strength.
Rijken DC; de Munk GA; Jie AF
Thromb Haemost; 1993 Nov; 70(5):867-72. PubMed ID: 8128448
[TBL] [Abstract][Full Text] [Related]
32. Electrochemical assay of plasminogen activators in plasma using polyion-sensitive membrane electrode detection.
Chang LC; Meyerhoff ME; Yang VC
Anal Biochem; 1999 Dec; 276(1):8-12. PubMed ID: 10585738
[TBL] [Abstract][Full Text] [Related]
33. The effect of chemical anti-inhibitors on fibrinolytic enzymes and inhibitors.
Sidelmann J; Jespersen J; Kluft C; Gram J
Clin Chim Acta; 1997 May; 261(1):43-56. PubMed ID: 9187504
[TBL] [Abstract][Full Text] [Related]
34. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
[TBL] [Abstract][Full Text] [Related]
35. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
Fukao H; Hagiya Y; Ueshima S; Okada K; Takaishi T; Izaki S; Matsuo O
Thromb Haemost; 1996 Feb; 75(2):352-8. PubMed ID: 8815589
[TBL] [Abstract][Full Text] [Related]
36. Fibrinolytic treatment by infusion of streptokinase-plasminogen-complex (activator): laboratory effects.
Martin H; Auel H; Riedel C
Behring Inst Mitt; 1986 Feb; (79):263-71. PubMed ID: 2424424
[TBL] [Abstract][Full Text] [Related]
37. [The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation].
Bashkov GV; Aĭsina RB; Kazanskaia NF; Makarov VA; Sirotenko AV; Popova GIu; Zhitkova IuV
Farmakol Toksikol; 1991; 54(2):46-50. PubMed ID: 1884796
[TBL] [Abstract][Full Text] [Related]
38. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
[TBL] [Abstract][Full Text] [Related]
39. [Enzymatic fibrinolytic agents].
Jamet M; Granthil C; Levy G
Ann Anesthesiol Fr; 1978; 19(8):693-6. PubMed ID: 31112
[TBL] [Abstract][Full Text] [Related]
40. The thrombolytic activity of streptokinase in the rabbit.
English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
